The first! China-made pen-type injector Inpacpen DCP® has secured FDA approval, marking a historic breakthrough for Chinese pharmaceutical-device combination products to enter the most strictly regulated global market.

  This achievement represents the third FDA-approved product from our company, following the Safetis® needle protector and InpacJector® Rüsch prefilled syringe (COP) . As a key component of the FDA-approved liraglutide injection, this pen injector demonstrates China's capability to produce high-quality pen injectors that meet global standards. After nearly two years of rigorous evaluation by major international regulators, it has now been deeply integrated into the global drug supply chain as a core supplier .

Our 25,000 square meter fully automated smart manufacturing facility, featuring a 9,300 square meter pen injector production line, has achieved "Shanghai Municipal Smart Factory" certification. With AI visual quality inspection systems and ERP/MES integration, the facility enables fully automated production from molding to packaging. The annual production capacity for self-injection pens now reaches 100 million units, continuously supplying high-quality Chinese-made injectors to global markets .